A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

To test their cutting-edge approach, the UW researchers focused on a well-studied enzyme called a serine hydrolase. The ...

Alzheimer’s disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from the ...

Alzheimer’s disease is the most common cause of dementia, a condition that affects memory, thinking, and behavior. It slowly ...

Now, researchers are taking a different path. There’s growing evidence that neuroinflammation—inflammation in the brain—plays a major role in causing and worsening Alzheimer’s. The new drug works by ...

between SOC and oxidase/hydrolase activity was found in the alpine meadow but not in the swamp meadow) between the two meadows. This indicates that carbon input and enzyme characteristics jointly ...

The poly-ubiquitin chain is synthesized by a cascade reaction involving three enzymes, E1 (ubiquitin-activating ... UCH-L1 (ubiquitin carboxyl-terminal hydrolase) and α-synuclein, whose mutations ...